Companies Johnson & Johnson FollowApril 27 (Reuters) - Johnson & Johnson (JNJ.N) said on Thursday it has agreed to retain all talc-related liabilities arising from litigation in the United States and Canada and will "indemnify" newly formed consumer health unit Kenvue for all costs.
"As unequivocally and unambiguously stated, Johnson & Johnson has agreed to retain all the talc-related liabilities -and indemnify Kenvue for any and all costs - arising from litigation in the United States and Canada.
Any suggestion to the contrary is false and misleading," Erik Haas, vice president of litigation, Johnson & Johnson, said in a statement.
The news comes as Johnson & Johnson (J&J) seeks a valuation of up to $42.95 billion for Kenvue in its initial public offering.
Their lawsuit claims Justin Bergeron contracted mesothelioma, a cancer associated with asbestos exposure, as a result of using J&J talc, FT reported.
Organizations:
& $